Log in to save to my catalogue

Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic M...

Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic M...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_366bac1877524f1aba6d51d5c33e7bbc

Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1

About this item

Full title

Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1

Publisher

Galenos Yayinevi Tic. Ltd

Journal title

Turk oftalmoloji gazetesi, 2023-12, Vol.53 (6), p.356-368

Language

English

Formats

Publication information

Publisher

Galenos Yayinevi Tic. Ltd

More information

Scope and Contents

Contents

Objectives: This study aimed to report the demographic and clinical characteristics of diabetic macular edema (DME) patients treated with intravitreal injection (IVI) of anti-vascular endothelial growth factors (anti-VEGF) and provide an overview of outcomes during routine clinical practice in Turkiye. Materials and Methods: This retrospective, rea...

Alternative Titles

Full title

Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_366bac1877524f1aba6d51d5c33e7bbc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_366bac1877524f1aba6d51d5c33e7bbc

Other Identifiers

ISSN

1300-0659

E-ISSN

2147-2661

DOI

10.4274/tjo.galenos.2023.56249

How to access this item